Erick Lucera
Chief Financial Officer · 5 filings · Latest: Aug 13, 2026
Dyne Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
DYN | Erick Lucera | Chief Financial Officer | Aug 13, 2026 | Sale | $26.28 | 1,797 | $47.2K | 119,766 | |
DYN | Lucera Erick | — | Aug 13, 2026 | Proposed Sale | $26.28 | 1,797 | $47.2K | — | |
DYN | Erick Lucera | Chief Financial Officer | Jun 25, 2026 | Sale | $20.37 | 2,362 | $48.1K | 121,563 | |
DYN | Lucera Erick | — | Jun 25, 2026 | Proposed Sale | $20.37 | 2,362 | $48.1K | — | |
DYN | Erick Lucera | Chief Financial Officer | May 13, 2026 | Sale | $18.36 | 1,448 | $26.6K | 123,925 | |
DYN | Lucera Erick | — | May 13, 2026 | Proposed Sale | $18.36 | 1,448 | $26.6K | — | |
DYN | Erick Lucera | Chief Financial Officer | Apr 1, 2026 | Sale | $18.64 | 5,727 | $106.8K | 125,373 | |
DYN | Lucera Erick | — | Apr 1, 2026 | Proposed Sale | $18.64 | 5,727 | $106.8K | — | |
EDIT | Lucera Erick | — | Mar 3, 2025 | Proposed Sale | $1.86 | 8,000 | $14.9K | — |